Pangenomic Health Inc.

Equities

NARA

CA69842E3041

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange 02:58:19 2024-04-24 pm EDT 5-day change 1st Jan Change
0.08 CAD 0.00% Intraday chart for Pangenomic Health Inc. 0.00% -60.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
PanGenomic Health plans to withdraw shares from Aquis Stock Exchange AN
Pangenomic Health Inc. Announces Changes to Board of Directors CI
PanGenomic Health agrees non-binding drawdown facility with Crescita AN
PanGenomic subsidiary reveals point-of-care vitamin D test AN
PanGenomic Health Subsidiary Introducing Point-of-Care Vitamin D Test for Dental Implant Industry MT
Pangenomic Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
PanGenomic Health's MUJN sells first biomarker tests AN
PanGenomic Health interim loss widens amid higher costs AN
Pangenomic Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Pangenomic Health Inc. Announces Director Resignations CI
PanGenomic subsidiary begins health assessment service AN
Pangenomic Health Inc. Announces Management Changes CI
Pangenomic Health Inc. Provides Update for Nara Product and Conversational Ai CI
PanGenomic Health buys CyberPatient licence for exclusive use AN
Pangenomic Health Inc. Signs Non-Binding Letter of Intent for an Exclusive Special Purpose Licence of the Cyberpatient Ai Medical Education Platform CI
Pangenomic Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
PanGenomic Health annual loss widens but "very pleased" with progress AN
Pangenomic Health Inc. Auditor Raises 'Going Concern' Doubt CI
Pangenomic Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Pangenomic Health Inc. Launches Its New Visual Identity, Website and E-Commerce Store for Its NARA Brand CI
Pangenomic Health Subsidiary Signs Rental Agreement with Psy Integrated Health, Makes Progress Towards Development of Joint Testing Facility CI
PanGenomic Health Inc. Announces its Nara Plant Library is Available Now on the Nara App CI
PanGenomic Health Announces Soft Launch of NARA Personalized DNA Reports, Closes Private Placement MT
Pangenomic Health Inc. announced that it has received CAD 0.51225 million in funding CI
Pangenomic Health Inc. to Launch E-Commerce Platform for Personalized Natural Health CI
Chart Pangenomic Health Inc.
More charts
Pangenomic Health Inc. is a precision health company. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform for consumers (Mindleap) and a clinical decision support platform for health practitioners (MUJN). The Nara mobile app provides consumers with a knowledge base, which is based on individual's user profile, leveraging input from mental health questionnaires, drug treatment regimen, genomic sequencing analysis, as well as their protein and microbiome biomarker reports. The Mindleap platform provides a variety of tools and resources to help individuals understand and improve their inner wellness. The MUJN clinical decision support platform provides health practitioners with access to the consumer's mobile app data and their diagnostic reports.
More about the company
  1. Stock Market
  2. Equities
  3. NARA Stock
  4. News Pangenomic Health Inc.
  5. PanGenomic Health Announces Soft Launch of NARA Personalized DNA Reports, Closes Private Placement